4.5 Article

Serum Lipopolysaccharide-binding Protein and Soluble CD14 Are Markers of Disease Activity in Patients with Crohn's Disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Endpoints for Clinical Trials Evaluating Disease Modification and Structural Damage in Adults with Crohn's Disease

Geert R. D'Haens et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Analysis of Cd14 as a Genetic Modifier of Experimental Inflammatory Bowel Disease (IBD) in Mice

Maike F. de Buhr et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Anti-microbial antibodies in celiac disease: Trick or treat?

Maria Papp et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

Jennifer Jones et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)

Review Critical Care Medicine

Biomarkers to improve diagnostic and prognostic accuracy in systemic infections

Philipp Schuetz et al.

CURRENT OPINION IN CRITICAL CARE (2007)

Article Gastroenterology & Hepatology

Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease

Oscar Pastor Rojo et al.

INFLAMMATORY BOWEL DISEASES (2007)

Article Gastroenterology & Hepatology

A simple biological score for predicting low risk of short-term relapse in Crohn's disease

Yann Consigny et al.

INFLAMMATORY BOWEL DISEASES (2006)

Review Immunology

The role of lipopolysaccharide-binding protein in modulating the innate immune response

Janine Zweigner et al.

MICROBES AND INFECTION (2006)

Review Gastroenterology & Hepatology

Oratory markers in IBD: Magic, or unneccessary toys?

S Vermeire et al.

Article Gastroenterology & Hepatology

A polymorphism in the CD14 gene is associated with Crohn disease

W Klein et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)